Read the receipt.
- Displayed amount
- $199 /30 tablets
- Delivery route
- Oral
- Product status
- FDA-approved medicine
- Membership in this figure
- See provider inclusions and terms
- Quantity
- 30 tablets
- Upfront commitment
- Confirm the initial charge and billing period
Separate clinical care and any applicable taxes or fees are not established by this medicine-only quote.
Sources: NovoCare — Wegovy pricing by formulation, Wegovy — prescribing information
What this price means.
The tablet strength determines the listed price. This is FDA-approved oral Wegovy, not a compounded semaglutide tablet or a dose-equivalent replacement for an injection. An older promotional price may differ from the current offer. Follow the prescription rather than choosing a strength based on its price.
Sources: NovoCare — Wegovy pricing by formulation, Wegovy — prescribing information
The product context.
Wegovy is an FDA-approved semaglutide medicine with formulation-specific labeling. Compounded semaglutide is not FDA-approved and is not a generic version of Wegovy. A provider’s starting price may apply to a particular strength or commitment. None of the prices here establishes that a preparation is appropriate or legally available for a particular patient.
Sources: Wegovy — prescribing information, FDA — compounding questions and answers, FDA — concerns with unapproved GLP-1 drugs
Before you pay.
What will actually be charged today?
Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- NovoCare — Wegovy pricing by formulation ↗
Official public information; price and terms checked October 8, 2026.
- Wegovy — prescribing information ↗
Formulation-specific approved uses, contraindications and warnings.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
- FDA — concerns with unapproved GLP-1 drugs ↗
Safety, dosing errors, salt forms and misleading online marketing.